Nuclear export is essential for the tumor-promoting activity of survivin

被引:118
作者
Knauer, Shirley K.
Kraemer, Oliver H.
Knoesel, Thomas
Engels, Knut
Roedel, Franz
Kovacs, Adorjan F.
Dietmaier, Wolfgang
Klein-Hitpass, Ludger
Habtemichael, Negusse
Schweitzer, Andrea
Brieger, Juergen
Roedel, Claus
Mann, Wolf
Petersen, Iver
Heinzel, Thorsten
Stauber, Roland H.
机构
[1] Georg Speyer Haus Inst Biomed Res, D-60596 Frankfurt, Germany
[2] Univ Jena, Inst Biochem & Biophys, D-6900 Jena, Germany
[3] Humboldt Univ, Charite CCM, Fac Med, Inst Pathol, D-1086 Berlin, Germany
[4] Univ Hosp Frankfurt, Dept Pathol, Frankfurt, Germany
[5] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-8520 Erlangen, Germany
[6] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
[7] Univ Hosp Essen, Inst Cell Biol, Essen, Germany
[8] Univ Hosp Mainz, Dept Otorhinolaryngol, Mainz, Germany
关键词
nucleocytoplasmic transport; apoptosis; Crm1; head and neck cancer; colorectal cancer; cancer therapy; LMB; cisplatin; valproic acid; HDAC;
D O I
10.1096/fj.06-5741com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Survivin appears to function as an apoptosis inhibitor and a regulator of cell division during development and tumorigenesis. Here we report the molecular characterization of the nucleocytoplasmic transport of survivin and its potential implications for tumorigenesis. We identified an evolutionary conserved Crm1-dependent nuclear export signal (NES) in survivin. In dividing cells, the NES is essential for tethering survivin and the survivin/Aurora-B kinase complex to the mitotic machinery, which in turn appears to be essential for proper cell division. In addition, export seems to be required for the cytoprotective activity of survivin, as export-deficient survivin fails to protect tumor cells against chemo- and radiotherapy-induced apoptosis. These findings appear to be clinically relevant since preferential nuclear localization of survivin correlated with enhanced survival in colorectal cancer patients. Targeting survivin's nuclear export by the application of NES-specific antibodies promoted its nuclear accumulation and inhibited its cytoprotective function. We demonstrate that nuclear export is essential for the biological activity of survivin and promote the identification of molecular decoys to specifically interfere with survivin's nuclear export as potential anticancer therapeutics.
引用
收藏
页码:207 / 216
页数:10
相关论文
共 42 条
[1]
Validating survivin as a cancer therapeutic target [J].
Altieri, DC .
NATURE REVIEWS CANCER, 2003, 3 (01) :46-54
[2]
Crm1 is a mitotic effector of Ran-GTP in somatic cells [J].
Arnaoutov, A ;
Azuma, Y ;
Ribbeck, K ;
Joseph, J ;
Boyarchuk, Y ;
Karpova, T ;
McNally, J ;
Dasso, M .
NATURE CELL BIOLOGY, 2005, 7 (06) :626-U27
[3]
Blanc-Brude OP, 2003, CLIN CANCER RES, V9, P2683
[4]
Clinical trial of valproic acid and all-trans retinoic acid in patients with poor-risk acute myeloid leukemia [J].
Bug, G ;
Ritter, M ;
Wassmann, B ;
Schoch, C ;
Heinzel, T ;
Schwarz, K ;
Romanski, A ;
Kramer, OH ;
Kampfmann, M ;
Hoelzer, D ;
Neubauer, A ;
Ruthardt, M ;
Ottmann, OG .
CANCER, 2005, 104 (12) :2717-2725
[5]
Survivin enhances radiation resistance in primary human glioblastoma cells via caspase-independent mechanisms [J].
Chakravarti, A ;
Zhai, GG ;
Zhang, M ;
Malhotra, R ;
Latham, DE ;
Delaney, MA ;
Robe, P ;
Nestler, U ;
Song, QH ;
Loeffler, J .
ONCOGENE, 2004, 23 (45) :7494-7506
[6]
Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition [J].
Dälken, B ;
Giesübel, U ;
Knauer, SK ;
Wels, WS .
CELL DEATH AND DIFFERENTIATION, 2006, 13 (04) :576-585
[7]
Mitochondrial dynamics of survivin and "four dimensional" control of tumor cell apoptosis [J].
Dohi, T ;
Altieri, DC .
CELL CYCLE, 2005, 4 (01) :21-23
[8]
An IAP-IAP complex inhibits apoptosis [J].
Dohi, T ;
Okada, K ;
Xia, F ;
Wilford, CE ;
Samuel, T ;
Welsh, K ;
Marusawa, H ;
Zou, H ;
Armstrong, R ;
Matsuzawa, S ;
Salvesen, GS ;
Reed, JC ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (33) :34087-34090
[9]
Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters [J].
Ferrandina, G ;
Legge, F ;
Martinelli, E ;
Ranelletti, FO ;
Zannoni, GF ;
Lauriola, L ;
Gessi, M ;
Gallotta, V ;
Scambia, G .
BRITISH JOURNAL OF CANCER, 2005, 92 (02) :271-277
[10]
Nucleocytoplasmic transport in apoptosis [J].
Ferrando-May, E .
CELL DEATH AND DIFFERENTIATION, 2005, 12 (10) :1263-1276